SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, vikingzskillz, Hyd
Search This Board: 
Last Post: 6/24/2017 2:59:38 AM - Followers: 487 - Board type: Free - Posts Today: 1

Anticipating an important update with relationship to this tweet "MAJOR Co. now holds first rights on . & Co. seeking raise by May 31st. Goal now to buyout tech shareholders entirely." For more on InWith Corp vist http://www.inwithcorp.com/ and Wilson Sonsini Goodrich & Rosati at https://www.wsgr.com/WSGR/Default.aspx

   


People, Products & Process:

As of the date of most currect disclosure (December 31, 2016), EPGL is structuring an up-coming relationship with a new start-up company called InWith Corporation, to begin in January 2017, for the purpose of building selected EPGL technologies.

EPGL has now received multiple USPTO patent allowances. EPGL expects to report within the next quarterly update, a decision from USPTO on any additional patent allowance(s). EPGL will inform our shareholders via public release immediately upon receiving such notice from the USPTO .

On April 12, 2016 EPGL signed an Agreement with Johnson & Johnson Vision Care, Inc. (JNJVC) . EPGL has several patents now pending in the field of ophthalmic technologies, specifically the integration of electronics into contact lenses for vision correction and augmented vision applications. JNJVC has secured exclusive rights of first negotiation to all EPGL ophthalmic technologies and patents pending. EPGL has received three (3) USPTO patent allowances since our last updated disclosure.

EPGL and CooperVision, Inc. reached a Settlement Agreement in December 2015. In December 2014, CooperVision, Inc. asked EPGL to grant the Exclusive Option to license EPGL jointly developed ophthalmic technologies. EPGL refused to do so, contending that the Development Agreement was breached and did not allow the granting of the Option for several more months after all joint IP was fully filed. EPGL threatened litigation over the issue. In May 2015, CooperVision, Inc. suggested mediation and EPGL agreed to do so. As announced publicly in a jointly approved January 2016 PR, after several months of negotiations, a settlement was reached whereby, to avoid litigation, the parties would agree that CooperVision, Inc. will retain rights and license to use the joint technology in their products in exchange for cash payment and EPGL receiving assignment of the IP

and 100% ownership control and marketing rights worldwide.

EP Global Communications, Inc., is a research and development company with focus on medical device design, ophthalmic medical device design, consumer electronic device design and device technologies in the IoT space.

In 2014, all EPGL technologies and Intellectual property were selected and put under Development Agreement by CooperVision, Inc., a leading medical device manufacturer, for development and marketing. The EPGL team is now securing Intellectual Properties and co-developing a family of advanced devices as a result. This Development Agreement was publicly disclosed on August 29, 2014. In addition, EPGL has entered an initial Agreement with Intel Corporation. EPGL has also entered into Agreements with AT&T as of January 2015. EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties.

EPGL Medical is the result of a reorganization which culminated in July 2012. With a strong team of medical and scientific professionals, the Company is poised to capture market share with innovative "smart medical and consumer electronic devices" technologies including those that require advanced microelectronic mechanical systems (MEMS). The Company philosophy is that healthcare is going

to become an increasingly challenging environment for both physicians and patients. A coming boom in patients simultatneous to a possible shortage of physicians will necessitate intuitive medical devices which can be used by a broader variety of doctors. In short, new "smart medical devices" advanced research and design intellectual properties will be needed more than ever. EPGL Medical has the know-how to develop technologies which fit this coming new healthcare environment and enable industry leaders to capture market share with those advanced technologies.

EP Global Communications, Inc. dba EPGL Medical, is a Delaware Corporation first incorporated November 17, 1999.

SIC Code 3841 - Surgical and medical instruments, Development Stage Company


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.
 

For more Information Visit https://portal.USPTO.GOV ALSO VISIT The World Intellectual Property Organization http://www.wipo.int/portal/en/index.html for information on REAL IP related to EP Global Communications DBA EPGL Medical
Below is a list of pending or granted IP that has been published
***. 3167695 ELASTIC CIRCUIT EP 17.05.2017
  .
 
15818698 MARKUS DAVID MARKUS DAVID
The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 
. 3123237 SYSTEM AND METHOD FOR CONTACT LENS WIRELESS COMMUNICATION EP 01.02.2017
G02C 7/04
 
 
15768969 MARKUS DAVID MARKUS DAVID
 
The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.

3104810 PIEZOELECTRIC SENSOR FOR VISION CORRECTION
EP 21.12.2016
A61F 2/16
 .
 
15749280 MARKUS DAVID MARKUS DAVID
 
The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscles attempt to focus the crystalline lens of the eye
 
 
WO/2016/161463 METHOD AND APPARATUS FOR AN IMAGING LENS WO 06.10.2016
G02C 7/02
 
 
PCT/US2016/025947 MARKUS, David MARKUS, David
 
The present invention is a method and apparatus projecting an image or series of images onto the retina. Furthermore, the present invention is neither cumbersome nor obstructive to the user. This is accomplished by embedding an imaging lens on the perimeter of the contact lens adapted to project an image inward toward the center of the contact lens, wherein the projected light will then be redirected onto the retina
 
WO/2016/073446 METHOD AND APPARATUS FOR AN ADAPTIVE FOCUS LENS WO 12.05.2016
G02B 3/14
.
 
PCT/US2015/058783 COOPERVISION INTERNATIONAL HOLDING COMPANY, LP MARKUS, David T.
 
Methods and apparatus are provided for adaptively focusing a lens. In one approach, electromagnetic energy is employed to modify a shape or thickness of a lens such that its refractive power and focal length are modified. In one aspect, a lens embodying adaptive focus features requires low power, and can be adjusted quickly. One or a plurality of electromagnets can be employed to compress or separate end portions of an embedded haptic, the force from which acts to alter the shape of the haptic, thus modifying the refractive power and focal length of a lens.
 
WO/2016/048941 MEDICAL DEVICE WITH PRE-DEFINED SPACE AND RELATED METHODS WO 31.03.2016
G02C 7/04
.
 
PCT/US2015/051321 EP GLOBAL COMMUNICATIONS, INC. MARKUS, David T.
 
A medical device including a pre-defined space such as a geometric shape or void. In one approach, the pre-defined space provides desired rigidity and more confort for a user. There is also provided an approach which enables engravings and accommodates electronics, mechanical objects, or other rigid or unique shapes to be embedded within a medical device such as a contact lens. When adapted to swellable substrates, the resulting swelled material can leave a gap around a perimeter of embbedded structure.
 
WO/2016/022665 ELECTRONIC MEDICAL DEVICES AND METHODS WO 11.02.2016
G02C 7/04
 
 
PCT/US2015/043783 EP GLOBAL COMMUNICATIONS, INC. MARKUS, David T.
 
The present disclosure provides an elastic electronic circuit adapted to provide three-dimensional elasticity while conforming to the curved or angled structures of a swellable medical device, such as a hydrogel or silicone hydrogel contact lens. The elastic electronic circuit can include a first pattern for flexibility in a first dimension, a second pattern for flexibility in a second dimension, and a third pattern for flexiblility in a third dimension. Alternatively, the elastic circuit can include a first pattern for flexibility in a first dimension and a second pattern for flexibility in a second dimension. The resulting three-dimensional elasticity enables the use of electronic circuits on soft contact lenses, where manufacture and use will cause the lenses and circuits to swell and shrink. Furthermore, the electronic circuit will not distort the vision correction of the contact lens or othwerwise cause discomfort or other negative side effects.
 
20160030160 Piezoelectric sensor for vision correction US 04.02.2016
G02C 7/08
.
 
14622814 David T. Markus David T. Markus
 

The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscle's attempt to focus the crystalline lens of the eye.

 
WO/2016/014118 PIEZOELECTRIC ENERGY HARVESTING CONTACT LENS WO 28.01.2016
A61B 3/16
.
 
PCT/US2015/015516 MARKUS, David MARKUS, David
 
The present invention will provide a piezoelectric energy-harvesting device in a contact lens that utilizes the multiplicity of constant forces generated by the eye for generating usable energy. The present invention will place a plurality of piezoelectric microdevices in direct or indirect contact with the eye, with the preferred embodiment in the form of a contact lens comprising an array of piezoelectric microdevices at the perimeter of a contact lens. These piezoelectric microdevices will harvest electrical energy generated by the mechanical forces applied by the various activities and movements of the eye, including, but not limited to, winking, squinting, blinking, rolling of the eyes, and vibration of the eyes.
 
20160014889 Elastic circuit US 14.01.2016
H05K 1/00
..
 
14794789 David T. Markus David T. Markus
 

The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 

WO/2016/007683 ELASTIC CIRCUIT WO 14.01.2016
H05K 1/02
 
 
PCT/US2015/039626 MARKUS, David MARKUS, David
 
The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 
20150281411 System for contact lens wireless communication US 01.10.2015
H04B 1/00
 
 
14668957 David T. Markus David T. Markus
 

The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.
 

WO/2015/148735 SYSTEM AND METHOD FOR CONTACT LENS WIRELESS COMMUNICATION WO 01.10.2015
G02C 7/04
 
 
PCT/US2015/022591 MARKUS, David MARKUS, David
 
The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.
 
WO/2015/123616 PIEZOELECTRIC SENSOR FOR VISION CORRECTION WO 20.08.2015
A61F 2/16
 
 
PCT/US2015/015978 MARKUS, David MARKUS, David
 
The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscles attempt to focus the crystalline lens of the eye.
 
The Company claims to have significant know-how and Intellectual Property in the arena of BioMEMS and claims to have invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 


 

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so.

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) - Court appointed
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company claims to have leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**
***************************************************************************************************************************************************************************************************
Helpful links to EPGL and the companies that are involved 


EPGL Medical  https://www.epglmed.com
InWith Corporation  
http://www.inwithcorp.com/ Looking to BUYOUT EPGL
CooperVision https://coopervision.com/ Devloped Joint IP with EPGL Medical, (reference) A. Back in filings
Wilson Sonsini Goodrich & Rosati https://www.wsgr.com/WSGR/Default.aspx In charge of Capital Raise for BUYOUT of EPGL
Pricewaterhousecoopers http://www.pwc.com/ Major shareholder requested this and granted by courts
Johnson & Johnson http://www.jnjvc.com/ Holding first rights to EPGL technologies
AT&T  https://www.att.com/ Joint IP developed with EPGL, anticiapte to see publications MID 2017










 

 

EPGL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#117812  Sticky Note Can't it be BOTH A and B? Me thinks Doubledown22 04/19/17 10:54:20 AM
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#120280   Yes a they have groups of bunny's to nbmedia 06/24/17 02:59:37 AM
#120279   When we go below 2s then they will Bibioo 06/23/17 10:45:44 PM
#120278   #disrupt? Or #Disapoint? Volcanridge 06/23/17 08:22:26 PM
#120277   They have clearly had a terrific impact on Stock Barber 06/23/17 06:34:09 PM
#120276   Anybody that wants to see a report on H8ster 06/23/17 05:19:24 PM
#120275   Old but IMPORTANT TWEETS: Donguri 06/23/17 05:14:43 PM
#120274   Why spend the money if the goal of H8ster 06/23/17 05:14:01 PM
#120273   All the tech in the patents is public H8ster 06/23/17 05:03:30 PM
#120272   Because they can be trusted to be honest Atlanta1 06/23/17 04:55:24 PM
#120271   Why on earth bunny hayes Will keep one nbmedia 06/23/17 04:54:47 PM
#120269   Why on earth would they waste their money H8ster 06/23/17 04:44:20 PM
#120267   What ever happened to full reporting to SEC? Donguri 06/23/17 04:35:53 PM
#120265   I think SHORTY is back. Donguri 06/23/17 04:27:29 PM
#120264   Very simple indeed. Majority of EPGL H8ster 06/23/17 03:44:26 PM
#120263   Uhggg... Day after day, week after week and shakamac 06/23/17 03:22:03 PM
#120262   Maybe the weekly reports will be delayed then nbmedia 06/23/17 09:33:11 AM
#120261   "The management team of InWith Corp. will be Atlanta1 06/23/17 08:50:45 AM
#120260   Rapidly ha Volcanridge 06/23/17 08:43:44 AM
#120259   I am Happy it is friday. As promised nbmedia 06/23/17 05:21:38 AM
#120258   How it could be a carrot while we franck92 06/23/17 12:47:27 AM
#120256   Just another false carrot... Stock Barber 06/23/17 12:16:07 AM
#120254   Here what I wait = "As of today franck92 06/23/17 12:05:56 AM
#120253   yes - it's simple. there is not enough Atlanta1 06/22/17 04:57:14 PM
#120252   Supply and demand is why we are here Doubledown22 06/22/17 04:50:13 PM
#120251   no - I'm saying that it's not any Atlanta1 06/22/17 04:37:56 PM
#120249   and it's the others - the thousands of Atlanta1 06/22/17 04:29:40 PM
#120248   Aware and convinced enough to purchase $EPGL....obviously. DD22 Doubledown22 06/22/17 04:26:57 PM
#120247   so that's supposed to be the universe of Atlanta1 06/22/17 04:24:30 PM
#120246   700 known $EPGL shareholders referenced in their "financials" Doubledown22 06/22/17 04:23:02 PM
#120244   what are you referring to as "market of Atlanta1 06/22/17 01:37:14 PM
#120243   My opinion is realistic. Do your own DD Quindien 06/22/17 01:32:50 PM
#120241   the market of 700 people? where on earth Atlanta1 06/22/17 11:50:14 AM
#120240   Thanks for your opinion. The "market" of 700 Quindien 06/22/17 11:47:12 AM
#120239   if the promised buyout at .098 happens, then Atlanta1 06/22/17 11:43:39 AM
#120237   with the hope that Hayes succeeds in transferring Atlanta1 06/22/17 11:09:44 AM
#120236   a couple of years ago the CEO put Atlanta1 06/22/17 11:08:32 AM
#120235   InWith is EPGLs hope. I am invested in Quindien 06/22/17 11:06:07 AM
#120233   In with was just a distraction come December Volcanridge 06/22/17 07:37:14 AM
#120230   InWith sminwith. Still waiting on the board Hank Kerchief 06/21/17 10:28:42 PM
#120229   What are you missing? We went from Hank Kerchief 06/21/17 10:24:17 PM
#120228   Uh. Yep. Ok. Sure. Right. Hmmmm. Hank Kerchief 06/21/17 10:21:12 PM
#120227   This makes zero sense. Quindien 06/21/17 10:19:19 PM
#120225   It can be done, but it's a horrible Quindien 06/21/17 10:18:03 PM
#120224   How do you know PwC wants nothing to Hank Kerchief 06/21/17 10:15:34 PM
#120223   We forfeited billions of shares when they did Hank Kerchief 06/21/17 10:14:09 PM
#120222   Why did the R/S only affect the float Hank Kerchief 06/21/17 10:08:31 PM
#120219   That's wrong. First off the r/s was done Quindien 06/21/17 09:04:38 PM
#120215   So are you suggesting the business is being Neophius 06/21/17 04:26:23 PM
#120214   No I said the patents alone are enough Valiant 06/21/17 04:24:50 PM
#120213   No, you admitted that you haven't. You said the Neophius 06/21/17 04:23:49 PM
PostSubject